METFORMIN IN OBESE ADOLESCENTS PREDISPOSED TO TYPE II DIABETES

点击翻译按钮获取中文摘要

Obese adolescents with insulin resistance are predisposed to the development of Type II diabetes mellitus in adulthood . This study examines the effects of Metformin on insulin sensitivity in obese adolescents with elevated fasting insulin levels and first degree relatives with Type II diabetes. The trial is double-blind and placebo controlled. In the study, obese adolescents undergo a rapid intravenous glucose tolerance test, permitting baseline assessment of insulin sensitivity using the Bergman minimal model. Patients are then assigned to drug or placebo groups for a total of six months, with monitoring of fasting plasma glucose, insulin, glycosylated hemoglobin, plasma lipids and weight, blood pressure and total body fat. Insulin sensitivity is assessed at the end of the trial by repeating the intravenous glucose tolerance test. Enrollment of patients and all testing have now been completed. We are currently in the initial phases on analyzing the data. The results of these studies may provide a new approach to the prevention of diabetes mellitus in patients predisposed to the disease.